Siren »

Hemab Therapeutics Holdings shares owned by Siren

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by Siren from 13F filings

Historical chart of Siren investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by Siren

Quarter filed Position value Share count Share price at filing
2026-06-30 $77M 2.1M 36.73

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Erasca (ERAS)
Veradermics Common Stock (MANE)
Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Bicara Therapeutics (BCAX)
Arrowhead Pharmaceuticals (ARWR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Rhythm Pharmaceuticals (RYTM)
Lexicon Pharmaceuticals Com New (LXRX)
Enliven Therapeutics (ELVN)
Spyre Therapeutics Com New (SYRE)
Parabilis Medicines

View all positions for Siren

Top funds holding Hemab Therapeutics Holdings

RA Capital Management
Novo A/S
FMR
Capital Research and Management Company - Division 3
Deep Track Capital
Siren
venBio Select Advisor
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Vanguard Capital Management
Driehaus Capital Management
Rock Springs Capital Management
Bellevue Group
Citadel Advisors
BlackRock

View all funds holding Hemab Therapeutics Holdings